Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
CCO Oncology Podcast - Podcast autorstwa Clinical Care Options
Kategorie:
Listen to CLL experts Jeff Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from live CCO Webinars on optimizing BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL).
